Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart
Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that Cardiol's President and Chief Executive Officer, David Elsley, will participate in a live interview on X with
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-14 7:27 AM EDT | Cardiol Therapeutics Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-09 8:30 AM EDT | Akanda Corp
FloraWorks Announces TruCBN(TM) Readiness for the CMS Substance Access BEI Program with Full Clinical and Safety Substantiation
Portland, Oregon--(Newsfile Corp. - April 9, 2026) - FloraWorks today announced that TruCBN™ 50 mg softgels are available to healthcare organizations evaluating sleep-focused hemp products for the CMS Substance Access Beneficiary Engagement Incentive (BEI) program. In a published 1,020-person randomized, double-blind, placebo-controlled clinical trial, TruCBN™ 50 mg dose demonstrated statistically significant improvement in sleep quality. Real-world evidence has
Technology, Cannabis, Health, Cannabis Manufacturer
2026-04-09 8:00 AM EDT | FloraWorks
Akanda Adjourns Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced that on March 31, 2026, it convened and subsequently adjourned its Special Meeting of Shareholders (the "Meeting") without transacting any business due to the absence of a quorum. The Meeting has been adjourned and will be reconvened in person in Toronto, Ontario on Monday, April 27, 2026 at 10:00 a.m. (Eastern Time). The adjournment provides
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-07 8:30 AM EDT | Akanda Corp
Simply Solventless Provides Restructuring Update, Including Expected Timing, and Announces Management Change
Calgary, Alberta--(Newsfile Corp. - April 6, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to provide an update regarding the previously announced restructuring of Massive Hash Factory Ltd. ("MHF"), CannMart Inc. ("CannMart"), and ANC Inc. ("ANC") (and collectively with MHF and CannMart, the "CCAA Appl
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-04-06 6:00 AM EDT | Simply Solventless Concentrates Ltd.
Cardiol Therapeutics Announces Year-End 2025 Update on Operations
Initiated pivotal Phase III MAVERIC trial of CardiolRx™ in recurrent pericarditis and surpassed 50% patient enrollment, with full enrollment expected in Q2 2026. Reported positive Phase II ARCHER data showing CardiolRx™ significantly reduced left ventricular mass in patients with acute myocarditis; results published in ESC Heart Failure. Advanced CRD-38 program, a novel next generation drug intended for use in heart failure an
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-04-01 7:27 AM EDT | Cardiol Therapeutics Inc.
City View Investee Company ArkenYield Secures Circle Alliance Partnership
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View"), announces that its investee company ArkenYield, a builder of stablecoin liquidity and yield infrastructure, has joined the Circle Alliance Program, positioning the Company among a select group of infrastructure providers and fintech platforms building directly with USDC. This milestone places ArkenYield alongside leading participants i
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-04-01 6:30 AM EDT | City View Green Holdings Inc.
Captiva Verde Welcomes Josh F.W. Cook to the Advisory Board
Jacksonville, Florida--(Newsfile Corp. - March 30, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces the appointment of Josh F.W. Cook to the Advisory Board. Josh F.W. Cook is a seasoned government executive and communications consultant with over 30 years of experience solving complex political and natural resource conflicts in California, Arizona, and Nevada. Josh most recently served as EPA Administrator for R
Agriculture, Cannabis, Cannabis Manufacturer
2026-03-30 9:00 AM EDT | Captiva Verde Wellness Corp.
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Strategic closure and planned sale of Eloy cultivation facility expected to improve Arizona profitability and enhance free cash flow. Proceeds from the sale to facilitate debt reduction, with key equipment redeployed to the Ohio market, saving approximately $2 million in capital expenditures to support Vext's build-out in the State. Plans to seek approval to expand Jackson cultivation to support a growing retail footprint a
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-03-30 7:30 AM EDT | VEXT Science, Inc.
Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition
Toronto, Ontario--(Newsfile Corp. - March 26, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its wholly owned subsidiary, First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, are pleased to announce an expansion of its dark fiber network with the addition of approximately 200 kilometres, increasing total network coverage to approximately 900 kilometres across Central Mexico. This milestone is expected to material
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-03-26 8:30 AM EDT | Akanda Corp
Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces the closing of (i) the first tranche of its non-brokered private placement (the "Offering") for gross proceeds of C$859,653.47, led by Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together with the
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-20 9:16 AM EDT | Psyched Wellness Ltd.
Delivra Health Brands Launches Dream Water(R) Kids Sleep Gummies in the United States Market
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its Dream Water® brand is launching its new Dream Water Kids Sleep Gummies in the US market. Dream Water Kids Sleep Gummies are expected to be available to Company distributors, retailers and e-c
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 5:30 PM EDT | Delivra Health Brands Inc.
City View Announces Filing of Change of Business Documents with the CSE
Toronto, Ontario--(Newsfile Corp. - March 19, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that it has filed the necessary Form 2A Listing Statement with the CSE providing full disclosure on the new business model in connection with its proposed change of business from an "industrial issuer" to an "investment issuer" (the "Proposed COB"). In connection with the Proposed COB and subject to CSE approval, the Company inten
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-03-19 7:00 AM EDT | City View Green Holdings Inc.
Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94
Toronto, Ontario--(Newsfile Corp. - March 11, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of health and wellness products derived from the Amanita Muscaria mushroom, is excited to announce that it has entered into a non-binding memorandum of terms (the "Term Sheet") with Gotham Green Fund III, L.P. and Gotham Green Fund III (Q), L.P. (together,
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2026-03-11 8:54 AM EDT | Psyched Wellness Ltd.
Vext Advances Ohio Expansion with Seventh Retail Location
Secures provisional dual-use license for Columbus dispensary, with operations expected to begin in Q4 2026, subject to regulatory approvals. Marks Vext's seventh dispensary in Ohio, and second in Columbus, as the Company advances toward the state's eight-store cap. Scales vertically integrated footprint in Ohio, positioning Vext to drive operating leverage and cash flow growth as additional retail locations come online and s
Cannabis, Cannabis Cultivator, Cannabis Dispensary, Cannabis Manufacturer
2026-03-03 5:00 PM EST | VEXT Science, Inc.
Simply Solventless Announces Endorsement and Support of Restructuring Plan from Secured Debt Holders
Calgary, Alberta--(Newsfile Corp. - March 2, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") announces that Plaza Capital ("Plaza"), SSC's largest secured convertible debenture ("CD") holder, and Altek Acquisition Partnership ("AAP"), SSC's largest promissory note ("PN") holder (and one of SSC's largest shareho
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-03-02 8:00 AM EST | Simply Solventless Concentrates Ltd.
Delivra Health and Its Brands LivRelief (TM) and Dream Water (TM) Report Results for Second Quarter of Fiscal 2026
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2026) - Delivra Health Brands Inc. (TSXV: DH
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-02-27 6:45 PM EST | Delivra Health Brands Inc.
Simply Solventless Commences Restructuring Process for the Benefit of Shareholders and Stakeholders
Calgary, Alberta--(Newsfile Corp. - February 27, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") announces that it has commenced a restructuring process for the benefit of SSC's shareholders and stakeholders (the "Restructuring"). The Restructuring is intended to maximize value and balance sheet strength for shareholders, creditors, and other stakeholders (the "Stakeholders"). It is expected that SSC's common shares will continue to trade on the
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2026-02-27 5:05 PM EST | Simply Solventless Concentrates Ltd.
First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico
Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-02-27 8:30 AM EST | Akanda Corp
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that it will participate at the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Members of management will present on March 4, 2026, at 10:30 a.m. EST.
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-02-25 7:27 AM EST | Cardiol Therapeutics Inc.